| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781940A A group of long acting anti-retrovirus polypeptides and their preparing method and use |
| 06/07/2006 | CN1781939A Amidated horseshoe crab anti-endotoxin factor circular analogue peptide molecule, its synthetic method and use |
| 06/07/2006 | CN1781938A Method for preparing echinocandin derivatives |
| 06/07/2006 | CN1781937A Amidated horseshoe crab anti endotoxin factor linear analogue peptide molecule, its synthetic method and use |
| 06/07/2006 | CN1781930A Deoxy nucleotide containing CpG single chain as adjuvant of hepatitis B virus vaccine |
| 06/07/2006 | CN1781929A Deoxy nucleotide containing CpG single chain as adjuvant of rabies vaccine |
| 06/07/2006 | CN1781916A Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/07/2006 | CN1781911A Intermediate for producing novel pyrazine derivatives |
| 06/07/2006 | CN1781553A Subunit vaccine of H5N1 subtype bird flu virus gene ergineering and its preparing method |
| 06/07/2006 | CN1781552A Stenotrophomonasmal-tophilia vaccine and its preparing method |
| 06/07/2006 | CN1781546A Recovery mixture for liver, gallbladder and stomach and its preparing method |
| 06/07/2006 | CN1781544A Medicinal composition for treating chronic hepatitis and its preparing method |
| 06/07/2006 | CN1781543A Ant oil liniment and its preparing method |
| 06/07/2006 | CN1781537A Shengmai injection and its preparing method |
| 06/07/2006 | CN1781533A Health restoring agastache dripping pill preparation and its preparing method |
| 06/07/2006 | CN1781522A Chinese medicine composition for treating avian flu |
| 06/07/2006 | CN1781517A Medicine containing zinc element for treating rhinitis and other disease |
| 06/07/2006 | CN1781515A External sterilizing Mongolian medicine lotion for skin and external genital organs |
| 06/07/2006 | CN1781514A Medicinal composition for treating keratitis caused by herpes zoster |
| 06/07/2006 | CN1781485A Improved entecavir oral disintegrating tablet and its preparing method |
| 06/07/2006 | CN1258587C Liquid soap containing trichlorophenylurea and its preparing method |
| 06/07/2006 | CN1258537C Method for preparing polypeptide soluble in aqueous solvent in absence of detergent |
| 06/07/2006 | CN1258535C Process for preparation of metal salt of clavulanic acid |
| 06/07/2006 | CN1258531C Aminomethyl pyrrolidine derivatives having aromatic substituents |
| 06/07/2006 | CN1258378C Medicinal ointment for treating onychomycosis, flat wart and cindyloma acuminatum |
| 06/07/2006 | CN1258364C Formula of cucurbitacin dripping pills and its preparation method |
| 06/07/2006 | CN1258359C Pharmaceutical compositions |
| 06/06/2006 | USH2158 Process for the production of clavulanic acid salts |
| 06/06/2006 | US7057076 which have improved receptor binding affinity via substituted alkyl side chains at the c-3 position; may contain terpene funtionality combined with resorcinol moieties; for treatment of nervous system disorders and cardiovascular disorders |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056933 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc. |
| 06/06/2006 | US7056915 Compounds useful as reversible inhibitors of cysteine proteases |
| 06/06/2006 | US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria |
| 06/06/2006 | US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | US7056895 1-(3,4-dihydroxy-5-methylol-tetrahydrofur-2-yl),3-amidino-1H-1,2,4- triazoles; infections, infestations, autoimmune diseases; anticarcinogenic and -tumor agents; HIV, hepatitis C, human papilloma virus and giant cell arteritis |
| 06/06/2006 | US7056704 RNA interference mediating small RNA molecules |
| 06/06/2006 | US7056700 Use of ClyA hemolysin for excretion of proteins |
| 06/06/2006 | US7056663 Diagnosing mammary gland cancer in humans; obtain target cells, obtain nucleotide sequences, screen for deletion of heterozygosity anf preferential chromosomal position, classify sample, loss of heterozygosity indicate tumor |
| 06/06/2006 | US7056521 Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
| 06/06/2006 | US7056514 Partial peptide mimetics and methods |
| 06/06/2006 | US7056510 Streptococcus pneumoniae SP036 polynucleotides, polypeptides, antigens and vaccines |
| 06/06/2006 | US7056492 Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle |
| 06/06/2006 | CA2457852C Multivesicular emulsion topical delivery systems |
| 06/06/2006 | CA2376706C Antifungal oral composition containing itraconazole and process for preparing same |
| 06/06/2006 | CA2327723C Bicyclic hydroxamic acid derivatives |
| 06/06/2006 | CA2215066C Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/06/2006 | CA2154572C Use of riluzole for the treatment of neuro-sida |
| 06/06/2006 | CA2133080C Calanolide antiviral compounds, compositions and uses thereof |
| 06/06/2006 | CA2116980C Chimeric and/or growth-restricted flaviviruses |
| 06/03/2006 | CA2526272A1 Polypeptides involved in candida biofilm formation and uses thereof |
| 06/01/2006 | WO2006057616A1 A composition comprising at least 3 different diols |
| 06/01/2006 | WO2006057454A1 A method of prime-boost vaccination |
| 06/01/2006 | WO2006057303A1 Glycopeptide antibiotic monomer derivatives |
| 06/01/2006 | WO2006057288A1 Glycopeptide antibiotic dimer derivatives |
| 06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
| 06/01/2006 | WO2006056877A2 Diazepine oxazolidinones as antibacterial agents |
| 06/01/2006 | WO2006056801A1 Composition comprising a polysaccharide with bacteria blocking action |
| 06/01/2006 | WO2006056142A1 Cpg single-strand deoxynucleotides for use as adjuvant |
| 06/01/2006 | WO2006056138A1 Use of jerusalem artichoke to produce medicaments for inhibiting and eliminating human papilloma virus hpv and improving human immunity |
| 06/01/2006 | WO2006056031A1 Use of ferrous ions for increasing the immunoreactivity of immunoglobulin preparations |
| 06/01/2006 | WO2006056006A1 Equine west nile virus immunotherapy |
| 06/01/2006 | WO2006024240A3 Vaccine composition against hepatitis c virus |
| 06/01/2006 | WO2006020720A3 Stable pegylated interferon formulation |
| 06/01/2006 | WO2006018185A8 Dihydropteridinones for the treatment of cancer diseases |
| 06/01/2006 | WO2005037866A8 Igg3 anti rhesus-d in the line yb2/0 having a high phagocytosis activity |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060116518 Novel phenanthridines |
| 06/01/2006 | US20060116411 Medicinal composition containing triazole compound |
| 06/01/2006 | US20060116401 Antibacterial compounds |
| 06/01/2006 | US20060116400 Oxazolidinone and/or isoxazoline derivatives as antibacterial agents |
| 06/01/2006 | US20060116394 Fab I inhibitors |
| 06/01/2006 | US20060116389 Antibacterial oxazolidinones |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116356 Phosphonate analogs of HIV integrase inhibitor compounds |
| 06/01/2006 | US20060116337 Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors |
| 06/01/2006 | US20060116326 Benzothiophene compounds having antiinfective activity |
| 06/01/2006 | US20060116325 Methods and compositions for inhibiting hiv-coreceptor interactions |
| 06/01/2006 | US20060115869 Uses of carbamoyl phosphate synthetas for the diagnosis of inflammatory diseases and sepsis |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 06/01/2006 | US20060115813 Intracellular signaling molecules |
| 06/01/2006 | US20060115542 Therapeutic delivery of carbon monoxide |
| 06/01/2006 | US20060115490 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection |
| 06/01/2006 | US20060115470 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 06/01/2006 | DE19910102B4 Proteinkonjugate, Verfahren, Vektoren, Proteine und DNA zu deren Herstellung, deren Verwendung, sowie Arzneimittel und Impfstoffe mit einem Gehalt derselben Protein conjugates, methods, vectors, proteins, and DNA for their preparation, their use, as well as drugs and vaccines containing the same |
| 06/01/2006 | CA2589250A1 Diazepine oxazolidinones as antibacterial agents |
| 06/01/2006 | CA2588285A1 Glycopeptide antibiotic monomer derivatives |
| 06/01/2006 | CA2586815A1 A composition comprising at least 3 different diols |
| 05/31/2006 | EP1661999A1 A method of preparing epitopes chimeric gene vaccine |
| 05/31/2006 | EP1661982A1 Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection |
| 05/31/2006 | EP1661904A1 Novel azalide and azalactam derivatives and process for the production of the same |
| 05/31/2006 | EP1661889A1 Chemokine receptor antagonist and medical use thereof |
| 05/31/2006 | EP1661883A1 13-substituted methacycline compounds |
| 05/31/2006 | EP1661882A1 Compound having anti-hcv activity and process for producing the same |
| 05/31/2006 | EP1661579A2 Method for treating diseases associated with changes of qualitative and/ quantitative composition of blood extracellular dna |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1660660A2 Polypeptides of streptococcus pyogenes |
| 05/31/2006 | EP1660522A2 Pharmaceutical composition with increased bioavailability suitable for the administration of oral retroviral protease inhibitors. process for preparing a concentrate pharmaceutical composition comprising a retroviral protease inhibitor |